TP53 and B-cell chronic lymphocytic leukemia: Taken together, our results suggest that the presence of TP53 alterations in monoallelic del(11q) CLL patients may contribute to a negative predictive impact due to an increase competitive fitness of CLL clones harboring both of these alterations.